Bacteria-host relationship: Ubiquitin ligases as weapons of invasion

Cell Research

Volumn 26, Issue 4, 2016, Pages 499-510

  Maculins, Timurs ^a,b   Fiskin, Evgenij ^a   Bhogaraju, Sagar ^c   Dikic, Ivan ^a,c  

^a GOETHE UNIVERSITY   (Germany)

^b FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^c Buchmann Institute for Molecular Life Sciences   (Germany)

Author keywords

bacteria; bacterial effectors; bacterial mimicry; ubiquitin ligases

Indexed keywords

UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; ENZYMOLOGY; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84960458024     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2016.30     Document Type: Review

References (102)

1. Kubori T, Galán JE. Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation. Cell 2003; 115:333-342.
2. Hardt WD, Chen LM, Schuebel KE, Bustelo XR, Galán JE. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 1998; 93:815-826.
3. Stender S, Friebel A, Linder S, Rohde M, Mirold S, Hardt WD. Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol Microbiol 2000; 36:1206-1221.
4. Stebbins CE, Galán JE. Structural mimicry in bacterial virulence. Nature 2001; 412:701-705.
5. Fu Y, Galán JE. A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 1999; 401:293-297.
6. Mueller CA, Broz P, Cornelis GR. The type III secretion system tip complex and translocon. Mol Microbiol 2008; 68:1085-1095.
7. Galán JE, Wolf-Watz H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 2006; 444:567-573.
8. Portaliou AG, Tsolis KC, Loos MS, Zorzini V, Economou A. Type III secretion: Building and operating a remarkable nanomachine. Trends Biochem Sci 2016; 41:175-189.
9. Diepold A, Armitage JP. Type III secretion systems: the bacterial flagellum and the injectisome. Philos Trans R Soc Lond B Biol Sci 2015; 370:20150020.
10. Cemma M, Brumell JH. Interactions of pathogenic bacteria minireview with autophagy systems. Curr Biol 2012; 22:R540-R545.
11. Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem 2006; 281:11374-11383.
12. Thurston TLM, Wandel MP, Muhlinen von N, Foeglein Á, Randow F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 2012; 482:414-418.
13. Kreibich S, Emmenlauer M, Fredlund J, et al. Autophagy proteins promote repair of endosomal membranes damaged by the Salmonella type three secretion system 1. Cell Host Microbe 2015; 18:527-537.
14. Ashida H, Kim M, Sasakawa C. Exploitation of the host ubiquitin system by human bacterial pathogens. Nat Rev Microbiol 2014; 12:399-413.
15. Capili AD, Lima CD. Taking it step by step: mechanistic insights from structural studies of ubiquitin/ubiquitin-like protein modification pathways. Curr Opin Struct Biol 2007; 17:726-735.
16. Vittal V, Stewart MD, Brzovic PS, Klevit RE. Regulating the regulators: Recent revelations in the control of E3 ubiquitin ligases. J Biol Chem 2015; 290:21244-21251.
17. Ikeda F, Dikic I. Atypical ubiquitin chains: new molecular signals. EMBO Rep 2008; 9:536-542.
18. Walczak H, Iwai K, Dikic I. Generation and physiological roles of linear ubiquitin chains. BMC Biol 2012; 10:23.
19. Dikic I, Wakatsuki S, Walters KJ. Ubiquitin-binding domains - from structures to functions. Nat Rev Mol Cell Biol 2009; 10:659-671.
20. Ulrich HD, Walden H. Ubiquitin signalling in DNA replication and repair. Nat Rev Mol Cell Biol 2010; 11:479-489.
21. Baumeister W, Walz J, Zühl F, Seemüller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 1998; 92:367-380.
22. Pearce MJ, Mintseris J, Ferreyra J, Gygi SP, Darwin KH. Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science 2008; 322:1104-1107.
23. Striebel F, Imkamp F, Sutter M, Steiner M, Mamedov A, Weber-Ban E. Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes. Nat Struct Mol Biol 2009; 16:647-651.
24. Cerda-Maira FA, McAllister F, Bode NJ, Burns KE, Gygi SP, Darwin KH. Reconstitution of the Mycobacterium tuberculosis pupylation pathway in Escherichia coli. EMBO Rep 2011; 12:863-870.
25. Wang T, Darwin KH, Li H. Binding-induced folding of prokaryotic ubiquitin-like protein on the Mycobacterium proteasomal ATPase targets substrates for degradation. Nat Struct Mol Biol 2010; 17:1352-1357.
26. Burns KE, Pearce MJ, Darwin KH. Prokaryotic ubiquitin-like protein provides a two-part degron to Mycobacterium proteasome substrates. J Bacteriol 2010; 192:2933-2935.
27. Cobbert JD, DeMott C, Majumder S, et al. Caught in action: selecting peptide aptamers against intrinsically disordered proteins in live cells. Sci Rep 2015; 5:9402.
28. Buell CR, Joardar V, Lindeberg M, et al. The complete genome sequence of the Arabidopsis and tomato pathogen Pseudomonas syringae pv. tomato DC3000. Proc Natl Acad Sci USA 2003; 100:10181-10186.
29. Dodds PN, Rathjen JP. Plant immunity: towards an integrated view of plant-pathogen interactions. Nat Rev Genet 2010; 11:539-548.
30. Oh CS, Martin GB. Effector-triggered immunity mediated by the Pto kinase. Trends Plant Sci 2011; 16:132-140.
31. Abramovitch RB, Janjusevic R, Stebbins CE, Martin GB. Type III effector AvrPtoB requires intrinsic E3 ubiquitin ligase activity to suppress plant cell death and immunity. Proc Natl Acad Sci USA 2006; 103:2851-2856.
32. Janjusevic R, Abramovitch RB, Martin GB, Stebbins CE. A bacterial inhibitor of host programmed cell death defenses is an E3 ubiquitin ligase. Science 2006; 311:222-226.
33. Zheng N, Schulman BA, Song L, et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002; 416:703-709.
34. Rosebrock TR, Zeng L, Brady JJ, Abramovitch RB, Xiao F, Martin GB. A bacterial E3 ubiquitin ligase targets a host protein kinase to disrupt plant immunity. Nature 2007; 448:370-374.
35. Ntoukakis V, Mucyn TS, Gimenez-Ibanez S, et al. Host inhibition of a bacterial virulence effector triggers immunity to infection. Science 2009; 324:784-787.
36. LaRock DL, Chaudhary A, Miller SI. Salmonellae interactions with host processes. Nat Rev Microbiol 2015; 13:191-205.
37. Lin DY, Diao J, Chen J. Crystal structures of two bacterial HECT-like E3 ligases in complex with a human E2 reveal atomic details of pathogen-host interactions. Proc Natl Acad Sci USA 2012; 109:1925-1930.
38. Lin DY, Diao J, Zhou D, Chen J. Biochemical and structural studies of a HECT-like ubiquitin ligase from Escherichia coli O157:H7. J Biol Chem 2010; 286:441-449.
39. Diao J, Zhang Y, Huibregtse JM, Zhou D, Chen J. Crystal structure of SopA, a Salmonella effector protein mimicking a eukaryotic ubiquitin ligase. Nat Struct Mol Biol 2007; 15:65-70.
40. Wood MW, Jones MA, Watson PR, et al. The secreted effector protein of Salmonella dublin, SopA, is translocated into eukaryotic cells and influences the induction of enteritis. Cell Microbiol 2000; 2:293-303.
41. Li M, Rosenshine I, Yu HB, et al. Identification and characterization of NleI, a new non-LEE-encoded effector of enteropathogenic Escherichia coli (EPEC). Microbes Infect 2006; 8:2890-2898.
42. Piscatelli H, Kotkar SA, McBee ME, et al. The EHEC type III effector NleL is an E3 ubiquitin ligase that modulates pedestal formation. PLoS One 2011; 6:e19331.
43. Tobe T, Beatson SA, Taniguchi H, et al. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci USA 2006; 103:14941-14946.
44. Scheffner M, Kumar S. Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects. Biochim Biophys Acta 2014; 1843:61-74.
45. Donnenberg MS, Hazen TH, Farag TH, et al. Bacterial factors associated with lethal outcome of enteropathogenic Escherichia coli infection: genomic case-control studies. PLoS Negl Trop Dis 2015; 9:e0003791.
46. Aravind L, Koonin EV. The U box is a modified RING finger - a common domain in ubiquitination. Curr Biol 2000; 10:R132-R134.
47. Hatakeyama S, Nakayama K-II. U-box proteins as a new family of ubiquitin ligases. Biochem Biophys Res Commun 2003; 302:635-645.
48. Wu B, Skarina T, Yee A, et al. NleG type 3 effectors from enterohaemorrhagic Escherichia coli are U-box E3 ubiquitin ligases. PLoS Pathog 2010; 6:e1000960.
49. Sievers F, Wilm A, Dineen D, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 2011; 7:539.
50. Goujon M, McWilliam H, Li W, et al. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res 2010; 38:W695-W699.
51. Hasegawa H, Holm L. Advances and pitfalls of protein structural alignment. Curr Opin Struct Biol 2009; 19:341-348.
52. Blasche S, Arens S, Ceol A, et al. The EHEC-host interactome reveals novel targets for the translocated intimin receptor. Sci Rep 2014; 4:7531.
53. Isberg RR, O'Connor TJ, Heidtman M. The Legionella pneumophila replication vacuole: making a cozy niche inside host cells. Nat Rev Microbiol 2009; 7:13-24.
54. Kubori T, Hyakutake A, Nagai H. Legionella translocates an E3 ubiquitin ligase that has multiple U-boxes with distinct functions. Mol Microbiol 2008; 67:1307-1319.
55. Quaile AT, Urbanus ML, Stogios PJ, et al. Molecular characterization of LubX: functional divergence of the U-box fold by Legionella pneumophila. Structure 2015; 23:1459-1469.
56. Ensminger AW, Isberg RR. E3 ubiquitin ligase activity and targeting of BAT3 by multiple Legionella pneumophila translocated substrates. Infect Immun 2010; 78:3905-3919.
57. Price CTD, Al-Quadan T, Santic M, Rosenshine I, Kwaik YA. Host proteasomal degradation generates amino acids essential for intracellular bacterial growth. Science 2011; 334:1553-1557.
58. Lomma M, Dervins-Ravault D, Rolando M, et al. The Legionella pneumophila F-box protein Lpp2082 (AnkB) modulates ubiquitination of the host protein parvin B and promotes intracellular replication. Cell Microbiol 2010; 12:1272-1291.
59. Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ, Parsot C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 2007; 1:77-83.
60. Singer AU, Rohde JR, Lam R, et al. Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases. Nat Struct Mol Biol 2008; 15:1293-1301.
61. Zhu Y, Li H, Hu L, et al. Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat Struct Mol Biol 2008; 15:1302-1308.
62. Zouhir S, Bernal-Bayard J, Cordero Alba M, et al. The structure of the Slrp-Trx1 complex sheds light on the autoinhibition mechanism of the type III secretion system effectors of the NEL family. Biochem J 2014; 464:135-144.
63. Keszei AFA, Tang X, McCormick C, et al. Structure of an SspH1-PKN1 complex reveals the basis for host substrate recognition and mechanism of activation for a bacterial E3 ubiquitin ligase. Mol Cell Biol 2014; 34:362-373.
64. Quezada CM, Hicks SW, Galán JE, Stebbins CE. A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases. Proc Natl Acad Sci USA 2009; 106:4864-4869.
65. Venkatesan MM, Goldberg MB, Rose DJ, Grotbeck EJ, Burland V, Blattner FR. Complete DNA sequence and analysis of the large virulence plasmid of Shigella flexneri. Infect Immun 2001; 69:3271-3285.
66. Buchrieser C, Glaser P, Rusniok C, et al. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol Microbiol 2000; 38:760-771.
67. Wei J, Goldberg MB, Burland V, et al. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun 2003; 71:2775-2786.
68. Jin Q, Yuan Z, Xu J, et al. Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res 2002; 30:4432-4441.
69. Ashida H, Toyotome T, Nagai T, Sasakawa C. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Mol Microbiol 2007; 63:680-693.
70. Ashida H, Kim M, Schmidt-Supprian M, Ma A, Ogawa M, Sasakawa C. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKγ to dampen the host NF-κB-mediated inflammatory response. Nat Cell Biol 2009; 12:66-73.
71. Fernandez-Prada CM, Hoover DL, Tall BD, Hartman AB, Kopelowitz J, Venkatesan MM. Shigella flexneri IpaH(7.8) facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages. Infect Immun 2000; 68:3608-3619.
72. Suzuki S, Mimuro H, Kim M, et al. Shigella IpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages. Proc Natl Acad Sci USA 2014; 111:E4254-E4263.
73. Ashida H, Nakano H, Sasakawa C. Shigella IpaH0722 E3 ubiquitin ligase effector targets TRAF2 to inhibit PKC-NF-κB activity in invaded epithelial cells. PLoS Pathog 2013; 9:e1003409.
74. Wang F, Jiang Z, Li Y, et al. Shigella flexneri T3SS effector IpaH4.5 modulates the host inflammatory response via interaction with NF-κB p65 protein. Cell Microbiol 2012; 15:474-485.
75. Tsolis RM, Townsend SM, Miao EA, et al. Identification of a putative Salmonella enterica serotype typhimurium host range factor with homology to IpaH and YopM by signature-tagged mutagenesis. Infect Immun 1999; 67:6385-6393.
76. Miao EA, Scherer CA, Tsolis RM, et al. Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems. Mol Microbiol 1999; 34:850-864.
77. Bernal-Bayard J, Ramos-Morales F. Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin. J Biol Chem 2009; 284:27587-27595.
78. Bernal-Bayard J, Cardenal-Munoz E, Ramos-Morales F. The Salmonella type III secretion effector, Salmonella leucine-rich repeat protein (SlrP), targets the human chaperone ERdj3. J Biol Chem 2010; 285:16360-16368.
79. Haraga A, Miller SI. A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol 2006; 8:837-846.
80. Auweter SD, Bhavsar AP, de Hoog CL, et al. Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners. J Biol Chem 2011; 286:24023-24035.
81. Bhavsar AP, Brown NF, Stoepel J, et al. The Salmonella type III effector SspH2 specifically exploits the NLR co-chaperone activity of SGT1 to subvert immunity. PLoS Pathog 2013; 9:e1003518.
82. Wiesner S, Ogunjimi AA, Wang HR, et al. Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell 2007; 130:651-662.
83. Leung KY, Reisner BS, Straley SC. YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Infect Immun 1990; 58:3262-3271.
84. Evdokimov AG, Anderson DE, Routzahn KM, Waugh DS. Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit. J Mol Biol 2001; 312:807-821.
85. Soundararajan V, Patel N, Subramanian V, Sasisekharan V, Sasisekharan R. The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation. Innate Immun 2011; 17:548-557.
86. McDonald C, Vacratsis PO, Bliska JB, Dixon JE. The Yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. J Biol Chem 2003; 278:18514-18523.
87. Höfling S, Grabowski B, Norkowski S, Schmidt MA, Rüter C. Current activities of the Yersinia effector protein YopM. Int J Med Microbiol 2015; 305:424-432.
88. LaRock CN, Cookson BT. The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe 2012; 12:799-805.
89. Cohen P, Tcherpakov M. Will the ubiquitin system furnish as many drug targets as protein kinases? Cell 2010; 143:686-693.
90. Murray MF, Jurewicz AJ, Martin JD, et al. A high-throughput screen measuring ubiquitination of p53 by human mdm2. J Biomol Screen 2007; 12:1050-1058.
91. Hong CA, Swearingen E, Mallari R, et al. Development of a high throughput time-resolved fluorescence resonance energy transfer assay for TRAF6 ubiquitin polymerization. Assay Drug Dev Technol 2003; 1:175-180.
92. Orlicky S, Tang X, Neduva V, et al. An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase. Nat Biotechnol 2010; 28:733-737.
93. Varfolomeev E, Blankenship JW, Wayson SM, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 2007; 131:669-681.
94. Vassilev LT, Vu BT, Graves B, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303:844-848.
95. Rossi M, Rotblat B, Ansell K, et al. High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. Cell Death Dis 2014; 5:e1203.
96. Maculins T, Carter N, Dorval T, et al. A generic platform for cellular screening against ubiquitin ligases. Sci Rep 2016; 6:18940.
97. Uetz P, Dong YA, Zeretzke C, et al. Herpesviral protein networks and their interaction with the human proteome. Science 2006; 311:239-242.
98. Mukhtar MS, Carvunis AR, Dreze M, et al. Independently evolved virulence effectors converge onto hubs in a plant immune system network. Science 2011; 333:596-601.
99. Hunter T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 2007; 28:730-738.
100. Wijdeven RH, Neefjes J, Ovaa H. How chemistry supports cell biology: the chemical toolbox at your service. Trends Cell Biol 2014; 24:751-760.
101. Ovaa H. Active-site directed probes to report enzymatic action in the ubiquitin proteasome system. Nat Rev Cancer 2007; 7:613-620.
102. An H, Statsyuk AV. Development of activity-based probes for ubiquitin and ubiquitin-like protein signaling pathways. J Am Chem Soc 2013; 135:16948-16962.